Viewing Study NCT03648333

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-01-08 @ 11:11 PM
Study NCT ID: NCT03648333
Status: COMPLETED
Last Update Posted: 2018-08-27
First Post: 2018-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)
Sponsor: Hanlim Pharm. Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Male Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None amlodipine View
None valsartan View
None hypertension View